Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Danube Pharmaceuticals names new CEO
Prior to joining Danube, Dr Katz served as executive vice president and chief medical officer of Fovea Pharmaceuticals in Paris. Before that Dr Katz was vice president for
Prior to joining Danube, Dr Katz served as executive vice president and chief medical officer of Fovea Pharmaceuticals in Paris. Before that Dr Katz was vice president for
The new development programs include response prediction to ovarian cancer treatment, predicting risk of gastric cancer recurrence, and differentiation of small cell from non-small cell lung cancer. The
Mr Tulstrup takes over as CEO from Keith McCullagh, who is retiring but will remain a member of the board of directors of the company. Prior to joining
The agreement marks the first immunotherapy clinical trial funded by Leukemia & Lymphoma Society’s (LLS) Therapy Acceleration Program, an innovative program designed to advance therapies with high prospects
The agreement provides comprehensive licensing rights and patent protection relating to Canopus’s Phase II oncology drug candidate, CB1400. Canopus BioPharma expects to develop CB1400 as a method for
The milestone was triggered by Genentech’s filing of an investigational new drug application with the FDA for an antibody-drug conjugate (ADC) utilizing Seattle Genetics’s technology. Under the terms
Fareed Kureshy, president and CEO of AutoGenomics, said: “This patent is the result of our collaboration with Dr Erik Thunnissen, a prominent clinician and opinion leader in the
Mr Taylor succeeds Roger Gale, who has resigned as president and CEO after completing a two-year term of employment. Mr Gale remains the chairman of Calypte’s board of
Vitrolife’s product Steen Solution is part of a new method for functional testing and preservation of lungs outside the body. The technology makes it possible for the first
Bryan Warwood, vice president of operations at BioSurface, said: “The Mbec assay fills an important customer need in biofilm research for a high throughput screening system. BioSurface Technologies